About Synapmed Global Private Limited
Data last updated:
Synapmed Global Private Limited is a private limited company based in Bangalore North, Karnataka, India, recognised as a startup by DPIIT. It operates in the healthtech and medical tech solutions segment of the healthcare sector. It was incorporated on 21 February 2020 and has been in existence for over 6 years.
The company is registered with the Registrar of Companies (ROC), Bangalore, under CIN U85100KA2020PTC132944. Its GSTIN is 29AATCA3386R1ZH (Karnataka).
The company has an authorised share capital of ₹5 Lakh and a paid-up capital of ₹1 Lakh. It is led by directors including Gargi Kumari (Whole-Time Director) and Jayalakshmi Maduranath.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at Bangalore North, Karnataka.
As per the financials filed for FY 2024, the company reported a revenue of ₹13.06 Cr, a growth of 27% compared to the previous year. For the same year it recorded a net profit of ₹1.19 Cr (net margin 9.1%) and EBITDA of ₹2.02 Cr (EBITDA margin 15.5%). Revenue has grown at a compounded annual rate (CAGR) of 32% over three years.
The company has about 54 employees on its provident fund (EPFO) records.
The company is associated with 1 brand: AstaLynx Global.
For more details, the company can be reached via its website astalynx.com.
- EmailLocked
- TelephoneLocked
- Website
- Social MediaLocked
- Registered AddressBrigade Opus, 70/401 5th Floor Kodigehalli Main Road Hebbal, Bangalore North, Karnataka, India – 560092
- IndustryHealthcare, HealthTech & Medical Tech Solutions
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
- One PDF report, delivered after checkout
Associated Brands with Synapmed Global Private Limited
Synapmed Global operates one associated brand: AstaLynx Global. Each brand links to its own profile.
| Brand | Description | Website |
|---|---|---|
| Provides pharmacovigilance, regulatory, and tech services to biopharma firms worldwide. | astalynx.com |
Competitors & Alternatives of Synapmed Global Private Limited
Brands and companies operating in the same space as Synapmed Global Private Limited include ProPharma Group, PharmaLex, Pharma-Bio Serv and 7 more.
| Competitor | Description | Location | Founded |
|---|---|---|---|
 ProPharma Group | Provider of regulatory compliance solutions to pharmaceutical, biotechnology and medical device | Saint Paul, United States | 2001 |
 PharmaLex | CRO specializing in regulatory affairs and pharmacovigilance | Mannheim, Germany | 1998 |
 Pharma-Bio Serv | Provider of regulatory compliance and validation support to life science industries | Dorado, Puerto Rico, United States | 1993 |
 Validant | Regulatory, compliance, and quality consulting for GxP lifecycles is provided. | San Francisco, United States | 2005 |
 Technical Safety Services | Healthcare instrumentation, medical gas systems, and related devices are manufactured. | Berkeley, United States | 1970 |
 Mapi Group | Real world evidence and post-approval research services are provided. | Lyon, France | 1990 |
 Clinical Outcomes Solutions | Regulatory support and consulting services are provided for clinical outcomes. | Tucson, United States | 2013 |
 Celegence | Regulatory consulting and solutions for pharmaceuticals and medical devices compliance. | Downers Grove, United States | 2017 |
 Trasis | Provides radiopharmaceutical equipment, synthesis solutions, and custom services for labs. | Ans, Belgium | 2004 |
 RLM Consulting | Provides regulatory support for bio-pharma from nonclinical to clinical development stages. | Namur, Belgium | 2007 |
Business Activity of Synapmed Global Private Limited
The main business activity of Synapmed Global is information and communication. In detail, this covers other information & communication service activities.
| Main Activity Group Code | Description of Main Activity | Business Activity Code | Description of Business Activity | Turnover Percentage |
|---|---|---|---|---|
| J | Information and communication | J8 | Other information & communication service activities | Locked |
Business activity turnover details
Turnover share and past changes in activity are in the company report.
- Turnover contribution
- Historical classifications
- Filing-level activity changes
Verified entity values are shown only after access is granted.
Auditor Details of Synapmed Global Private Limited
Synapmed Global Private Limited is audited by M K DANDEKAR & CO for the financial year 2023.
| Name | Status | Appointment Date | Cessation Date |
|---|---|---|---|
| M K DANDEKAR & CO | Locked | Locked | Locked |
Complete auditor history
Appointment and cessation dates and past auditor changes are in the company report.
- Appointment status
- Appointment dates
- Cessation dates
- Auditor changes
Verified entity values are shown only after access is granted.
Board of Directors of Synapmed Global Private Limited
Synapmed Global has 4 current directors and 6 former directors. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Jayalakshmi Maduranath | Director | 19 Oct 2023 | 2 Years 11 Months | Current |
| Krishnam Raj Kumar Pagadala | Additional Director | 23 Jan 2026 | 0 Years 8 Months | Current |
| Gaurav Mishra Also directs: Qaurus Consulting India Private Limited | Additional Director | 23 Jan 2026 | 0 Years 8 Months | Current |
| Gargi Kumari Also directs: Kretacx Software Private Limited, Theragenx Private Limited | Whole-Time Director | 01 Apr 2025 | 1 Years 6 Months | Current |
Financials of Synapmed Global Private Limited FY 2025 filings available
Synapmed Global Private Limited reported revenue of ₹13.06 Cr (up 27.00% YoY) for FY 2024.
Growth of Synapmed Global Private Limited
| Metric | 1-year growth | 3-year compounded (CAGR) |
|---|---|---|
| Revenue | ▲ 27% | ▲ 32% |
| Net profit | ▲ 24% | ▲ 197% |
| EBITDA | ▲ 29% | ▲ 194% |
Revenue has grown at a compounded annual rate (CAGR) of 32% over three years, including 27% growth in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary of Synapmed Global Private Limited
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | •••• | •••• | •••• | •••• | •••• |
| Other Income | •••• | •••• | •••• | •••• | •••• |
| Total Revenue | •••• | •••• | •••• | •••• | •••• |
| Cost of Materials Consumed | •••• | •••• | •••• | •••• | •••• |
| Employee Benefit Expense | •••• | •••• | •••• | •••• | •••• |
| Finance Costs | •••• | •••• | •••• | •••• | •••• |
| Depreciation and Amortisation | •••• | •••• | •••• | •••• | •••• |
| Other Expenses | •••• | •••• | •••• | •••• | •••• |
| Total Expenses | •••• | •••• | •••• | •••• | •••• |
| EBITDA | ₹2.02 Cr | •••• | •••• | •••• | •••• |
| Profit Before Tax | •••• | •••• | •••• | •••• | •••• |
| Tax Expense | •••• | •••• | •••• | •••• | •••• |
| Net Profit (PAT) | ₹1.19 Cr | •••• | •••• | •••• | •••• |
| Balance Sheet | |||||
| Share Capital | •••• | •••• | •••• | •••• | •••• |
| Reserves and Surplus | •••• | •••• | •••• | •••• | •••• |
| Net Worth (Total Equity) | •••• | •••• | •••• | •••• | •••• |
| Long-term Borrowings | •••• | •••• | •••• | •••• | •••• |
| Short-term Borrowings | •••• | •••• | •••• | •••• | •••• |
| Trade Payables | •••• | •••• | •••• | •••• | •••• |
| Total Liabilities | •••• | •••• | •••• | •••• | •••• |
| Fixed Assets | •••• | •••• | •••• | •••• | •••• |
| Investments | •••• | •••• | •••• | •••• | •••• |
| Inventories | •••• | •••• | •••• | •••• | •••• |
| Trade Receivables | •••• | •••• | •••• | •••• | •••• |
| Cash and Bank Balance | •••• | •••• | •••• | •••• | •••• |
| Total Assets | •••• | •••• | •••• | •••• | •••• |
Financial Ratios of Synapmed Global Private Limited
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 15.5% | •••• | •••• | •••• | •••• |
| Net Profit Margin | 9.1% | •••• | •••• | •••• | •••• |
| Return on Equity (ROE) | •••• | •••• | •••• | •••• | •••• |
| Return on Capital Employed (ROCE) | •••• | •••• | •••• | •••• | •••• |
| Return on Assets (ROA) | •••• | •••• | •••• | •••• | •••• |
| Liquidity and Debt | |||||
| Current Ratio | •••• | •••• | •••• | •••• | •••• |
| Quick Ratio | •••• | •••• | •••• | •••• | •••• |
| Debt-to-Equity Ratio | •••• | •••• | •••• | •••• | •••• |
| Interest Coverage Ratio | •••• | •••• | •••• | •••• | •••• |
| Efficiency and Growth | |||||
| Asset Turnover | •••• | •••• | •••• | •••• | •••• |
| Receivable Days | •••• | •••• | •••• | •••• | •••• |
| Payable Days | •••• | •••• | •••• | •••• | •••• |
| Inventory Days | •••• | •••• | •••• | •••• | •••• |
| Revenue Growth | •••• | •••• | •••• | •••• | •••• |
| Net Profit Growth | •••• | •••• | •••• | •••• | •••• |
Paid data: the figures shown as dots are available after purchase of the company report. Figures as filed with the MCA in Form AOC-4. The full year-wise statements and ratios of Synapmed Global are in the company report.
Financial statements from FY 2020
Earlier years and trend charts are in the company report.
- Income statements
- Balance sheets
- Cash-flow statements
- Ratios and benchmarks
Verified entity values are shown only after access is granted.
Ownership and Shareholding of Synapmed Global Private Limited
Shareholding and ownership data
Promoter, institutional, public and beneficial ownership figures are in the company report.
- Ownership categories
- Historical changes
- Group structure
- FII and DII holdings
Verified entity values are shown only after access is granted.
Charges & Borrowings of Synapmed Global Private Limited
Synapmed Global Private Limited does not have any charges (loans) registered with the Registrar of Companies.
Employees and EPFO Compliance at Synapmed Global Private Limited
Synapmed Global Private Limited has a workforce of 54 employees as of Mar 30, 2024.
Employee and EPFO history
Monthly headcount, contribution history and filing status are in the company report.
- Monthly headcount
- PF contributions
- ECR filing status
- Establishment history
Verified entity values are shown only after access is granted.
GST Compliance of Synapmed Global Private Limited
Synapmed Global has 1 GST registration: 1 active.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 29AATCA3386R1ZH | Karnataka | Active | 01 Mar 2020 |
GST registrations and filing compliance
State-wise GST registrations, return filing status and HSN or SAC codes are in the company report.
- GSTIN registrations
- State-wise filing status
- HSN and SAC details
- Tax jurisdiction records
Verified entity values are shown only after access is granted.
Credit Ratings, Litigation & Regulatory Alerts for Synapmed Global Private Limited
Credit ratings, litigation, and regulatory alerts
Credit ratings, court records and regulatory alerts are in the company report.
- Rating history
- Court and tribunal cases
- Regulatory alerts
- Director-linked violations
Verified entity values are shown only after access is granted.
MSME Payment Delays by Synapmed Global Private Limited
MSME payment history
Amounts due to small suppliers, the reasons given and MSME-1 filings are in the company report.
- Outstanding amounts
- Delay periods and reasons
- MSME-1 filing history
- Vendor payment signals
Verified entity values are shown only after access is granted.
Subsidiaries & Group Companies of Synapmed Global Private Limited
Corporate group structure
Parent, subsidiary, associate and joint venture records with holdings are in the company report.
- Parent company
- Subsidiaries and ownership
- Associates and joint ventures
- Entity investments
Verified entity values are shown only after access is granted.
MCA Filings & Documents of Synapmed Global Private Limited
MCA filings and documents
Filed forms, annual returns, financial statements and charge filings with their dates are in the company report.
- Incorporation documents
- Annual returns and statements
- Charge filings
- Complete filing index
Verified entity values are shown only after access is granted.
Recent Activity on Synapmed Global Private Limited
Frequently Asked Questions about Synapmed Global Private Limited
Synapmed Global is an active private limited company based in Bangalore North, Karnataka, India. The company works in healthtech and medical tech solutions, within the healthcare industry. It was incorporated on 21 February 2020 (6+ years old) and is registered under CIN U85100KA2020PTC132944.
Synapmed Global reported revenue of ₹13.06 Cr for FY 2024 (up 27.00% YoY).
Synapmed Global has 4 current directors:
- Gargi Kumari - Whole-Time Director
- Jayalakshmi Maduranath - Director
- Krishnam Raj Kumar Pagadala - Additional Director
- Gaurav Mishra - Additional Director
Synapmed Global reported a net profit of ₹1.19 Cr (net margin 9.1%) and EBITDA of ₹2.02 Cr (EBITDA margin 15.5%) for FY 2024, as per its filed financial statements.
The compounded annual growth rate (CAGR) of the revenue of Synapmed Global is 32% over three years. In the latest year (FY 2024) revenue rose 27%. CAGR is the steady yearly rate that links the first and the last year.
The GSTIN of Synapmed Global is 29AATCA3386R1ZH, registered in Karnataka.
The CIN (Corporate Identification Number) of Synapmed Global is U85100KA2020PTC132944. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Synapmed Global was incorporated on 21 February 2020, making it 6+ years old. It is registered with the Registrar of Companies, Bangalore.
Yes, Synapmed Global is recognised as a startup by the Department for Promotion of Industry and Internal Trade (DPIIT).